Companies › CLDI

CALIDI BIOTHERAPEUTICS INC (CLDI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001855485 · EDGAR filings · Updated 2026-07-16

CALIDI BIOTHERAPEUTICS INC (CLDI) has reported institutional ownership of 18.4%, with 28 institutional managers holding positions valued at $478.8K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-16 — Current report (8-K) filed
• 2026-06-29 — Initial insider ownership filed (Form 3)
• 2026-06-23 — Current report (8-K) filed
• 2026-06-18 — Current report (8-K) filed
• 2026-06-05 — DEFA14A filed
• 2026-05-29 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CALIDI BIOTHERAPEUTICS INC has 28 institutional holders and institutional ownership of 18.4%.

Insider activity

Insiders reported 5 transactions (4 buys, 1 sells) across 6 reporting insiders, with a net reported value of $453.8K.

Data flags from SEC filings

Related companies

INVO Fertility Inc (IVF) · Alps Group Inc (ALPS) · ARTELO BIOSCIENCES INC (ARTL) · EXOZYMES INC (EXOZ) · GeoVax Labs Inc (GOVX) · CADRENAL THERAPEUTICS INC (CVKD)